Skip to main content
  1. Right Decisions
  2. Back
  3. Dermatology pathways
  4. Rosacea
Please update your RDS mobile app to version 4.7.1

We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. When you install the update, you will see that each toolkit has a small QR code icon the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.

You may need to actively install the update to install RDS app version 4.7.1 to see this improvement. Installing this update is also strongly recommended to get the full benefits of the new contingency arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits. 

To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number.  To install latest updates:

On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Please get in touch with ann.wales3@nhs.scot with any questions.

Rosacea

Not all treatment options may be listed in this guidance. Please refer to local formulary for a complete list.

Treatment/ therapy

Rosacea is a chronic relapsing disorder with intermittent or persistent facial flushing, telangiectasia and pustules, in the absence of comedones. Rosacea can also cause ocular symptoms such as  dry gritty eyes. 

Rosacea

Rhinophyma 

Less commonly, rosacea can develop Rhinophyma where the shape and size of the nose changes

Rhinophyma

Rhinophyma

General Advice 

  • Give patient information sheet 
  • Advise about oil-free products 
  • Advise on UV protection 
  • Cosmetic camouflage may be helpful for flushing, erythema and telanglectasia which will not respond to topical or oral antibiotics 
  • Avoid exacerbating factors: spicy foods, alcohol, hot drinks, caffeine, temperature changes, sun exposure 

Topical Therapy 

  • Use topical agents for 2-3 months then intermittently as required 
  • Metronidazole gel or cream od 
  • Azelaic acid 15% gel or 20% cream od 
  • Ivermectin cream 10mg/g od 
  • Brimonidine 0.33% gel for temporary improvement of erythema as required od 

Systemic therapy 

  • 2-3 months courses required intermittently 
  • Lymecycline 408mg od 
  • Doxycline 200mg od 
  • Erythromycin 500mg bd 

Referral Management

Dermatology Referral Criteria 

  • Severe or unresponsive disease 

Consider  referral to Plastic Surgery 

  • Rhinophyma 
  • Severe telangiectasia 

Consider  referral to Ophthalmology or Optometry 

  • Eye symptoms or presence of keratitis 

Clinical tips

  • If no improvement after 3 months switch to alternative antibiotic 
  • Intermittent or continuous antibiotics may be required 

Patient information resources

Editorial Information

Author(s): Adapted from Dermatology Patient Pathways.

Co-Author(s): NHS Scotland, Scottish Dermatology Society.